Epigenome-Wide Association Study of the Upper-Airway Microbiome and Asthma Exacerbations — Preprin

Study metadata and preprint status

The document is a medRxiv preprint titled Epigenome-Wide Association Study of the Upper-Airway Microbiome Involved in Asthma Exacerbations with DOI https://doi.org/10.64898/2026.10.02.26364005. The hosting page includes the standard medRxiv notice that the manuscript is a preprint and has not undergone peer review. The medRxiv disclaimer that the report should not be used to guide clinical practice is explicitly included on the page.

Author list and institutional affiliations

The page displays a large, multidisciplinary author list. Lead affiliations reported include the Genomics and Health Group, Universidad de La Laguna (Spain) and associated biomedical technology institutes. Multiple coauthors are affiliated with hospitals, children’s hospitals, universities and public health institutions across several countries, including Spain, the United States, the Netherlands, Germany and Slovenia.

Many authors on the page have ORCID identifiers linked. The breadth of institutions suggests collaboration across genomics, pediatric, respiratory and public health specialties. Specific author names and multiple institutional affiliations are listed on the medRxiv page, but this excerpt does not include author contributions or funding statements.

Scope implied by title: EWAS, upper-airway microbiome, asthma exacerbations

The title indicates the study design and focal topics: an epigenome-wide association study (EWAS) examining the upper-airway microbiome in the context of asthma exacerbations. From the title alone, the intended objective appears to be exploration of associations between epigenetic variation across the genome and features of the upper-airway microbiome that are relevant to asthma exacerbation events.

The medRxiv excerpt does not contain the manuscript abstract or a lay summary, so the precise hypotheses, primary outcomes, exposures, timing (cross-sectional versus longitudinal), or the clinical definitions of asthma exacerbations used by the authors are not available in the provided content.

What information is present in the provided source excerpt

• The full title of the work.
• The DOI and medRxiv hosting information.
• The explicit preprint status and standard medRxiv caution about unrefereed content.
• A detailed author list with institutional affiliations spanning multiple countries.
• ORCID links for many individual authors.

What information is missing from the provided excerpt

The excerpt does not include critical study content necessary for clinical interpretation. Specifically, the following items were not reported in the provided source material:

• Abstract or structured summary (background, objectives, conclusions).
• Methods: study design, cohort selection, sample size, inclusion/exclusion criteria, specimen collection procedures, DNA methylation or epigenetic assay platforms, microbiome profiling methods, bioinformatic or statistical approaches, covariates, or correction for multiple testing.
• Results: identified epigenetic loci, associations with microbiome features or taxa, measures of effect size, confidence intervals, p-values, or other statistical outputs.
• Sensitivity analyses, subgroup analyses, replication cohorts, or validation strategies.
• Clinical interpretation, proposed mechanisms linking epigenetic marks and airway microbiota to asthma exacerbations, or translational recommendations.
• Funding sources, conflicts of interest, or ethical approvals.

Because these essential elements are absent from the supplied page excerpt, no summary of findings, numerical results, or clinical recommendations can be derived from this content alone.

Implications for clinicians and researchers

From the metadata and title, the preprint signals active research interest at the interface of epigenetics, the upper-airway microbiome, and clinical asthma outcomes. However, in the absence of the manuscript body, no evidence-based actions or changes to clinical practice are justified based on the excerpt alone. Clinicians and researchers should:

• Treat the work as preliminary until the full manuscript is available and peer-reviewed.
• Consult the complete preprint for methods, results and limitations before citing or applying any findings.
• Await peer review and, where possible, independent replication before integrating results into research designs or clinical guidelines.

How to access the full preprint and cautions about use

The medRxiv page includes the DOI above. To evaluate the study rigor and findings, readers must access the full preprint through medRxiv using the DOI or the URL provided on the hosting page.

Because the posted content is unrefereed, the medRxiv notice applies: the report should not be used to guide clinical practice. The supplied excerpt lacks core study details, and the present summary refrains from inferring results or making clinical recommendations absent those details. For complete assessment, consult the full preprint text and any subsequent peer-reviewed publication.